Caltech's Board of Trustees, which is gathering for a meeting this week, has welcomed two new members, both with experience in medical technology and business.
Richmond Wolf, a partner at Capital World Investors, and David Pyott, the former CEO of Allergan, were elected to the board in recent months. In total, the board comprises 45 trustees, 26 senior trustees, 20 life members, and one honorary life member.
We recently asked each of Caltech's newest board members to reflect on their careers and connection to the Institute. Read more about Wolf and Pyott.